Hims & Hers bigger-than-expected quarterly loss overshadows revenue forecast raise

It, however, raised its full-year revenue guidance to $3.1 billion to $3.3 billion from $2.8 billion to $3 billion previously.

Hims said that the forecast raise included Eucalyptus, an Australian digital health company that Hims agreed to acquire in February.

"Even if you pull out Eucalyptus (from the guidance), the domestic business and the existing international business were already ahead of our guidance range," Yemi Okupe, chief financial officer, told Reuters.

Hims said it was confident about reaching its goal of $6.5 billion in revenue by 2030.

"The results/guidance was not a complete surprise to us, as core growth did appear solid," said Leerink Partners analysts, adding that it was unclear if consensus included the Eucalyptus acquisition in their estimates.